Cargando…
Anti-TNF-α Therapies in Systemic Lupus Erythematosus
Tumor necrosis factor (TNF)-α is not just a proinflammatory cytokine. It has also been proposed to be an immunoregulatory molecule that can alter the balance of T regulatory cells. Anti-TNF-α therapies have been provided clinical benefit to many patients and introduced for treating moderate to sever...
Autores principales: | Zhu, Lang-Jing, Yang, Xiao, Yu, Xue-Qing |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896679/ https://www.ncbi.nlm.nih.gov/pubmed/20625488 http://dx.doi.org/10.1155/2010/465898 |
Ejemplares similares
-
Cytokines in Systemic Lupus Erythematosus—Focus on TNF-α and IL-17
por: Richter, Patricia, et al.
Publicado: (2023) -
Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agents
por: Dalle Vedove, Camilla, et al.
Publicado: (2012) -
Clinical and immunological effects of anti-TNF therapy in systemic lupus erythematosus (SLE)
por: Aringer, M, et al.
Publicado: (2003) -
TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus
por: Idborg, Helena, et al.
Publicado: (2018) -
Anti-Cytokine Autoantibodies in Systemic Lupus Erythematosus
por: Howe, Hwee Siew, et al.
Publicado: (2019)